MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0000619
Naprod Life Sciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹219.65 Cr
▲ 1% YoY
Net profit · FY 2025
₹19.5 Cr
Net margin 8.9%
EBITDA · FY 2025
₹34.7 Cr
EBITDA margin 15.8%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.02 Cr
Issued & subscribed
Open charges
₹56.1 Cr
Satisfied ₹9.24 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
504
Provident fund records
About Naprod Life Sciences Private Limited
Data last updated:
Naprod Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 July 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1990PTC057496. Its GSTIN is 27AAACN1291M1Z9 (Maharashtra).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.02 Cr. It was formerly known as Neon Antibiotics Private Limited. It is led by directors including Manish Babulal Jain and Mohan Babulal Jain.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 304 Town Centre Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹219.65 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹19.5 Cr (net margin 8.9%) and EBITDA of ₹34.7 Cr (EBITDA margin 15.8%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 7% over five years.
The company has about 504 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Naprod Life Sciences. As per MCA filings, the company has open charges of ₹56.1 Cr and satisfied charges of ₹9.24 Cr on record. Court records list 16 cases involving the company, including 4 filed by the company and 12 filed against it; 1 case is pending. The company has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.52 Cr; the latest was in March 2022. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Venus Biosciences Private Limited with revenue of ₹222.32 Cr.
Naprod Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0000619). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naprodgroup.com.
Company details
CIN U24230MH1990PTC057496
Registration Number 057496
Incorporation Date 30 July 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0000619
Recognitions & Rankings of Naprod Life Sciences
Contact details
Naprod Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is naprodgroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address304 Town Centre Andheri Kurla Road Andheri (East), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Naprod Life Sciences Private Limited, buy the company report.
Comprehensive company report
Naprod Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Naprod Life Sciences operates one associated brand: Naprod Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of oncology and anesthesia pharmaceuticals in India. | naprodgroup.com |
Business activity
The main business activity of Naprod Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Naprod Life Sciences Private Limited, buy the company report.
Financials of Naprod Life Sciences Private Limited
FY 2025 filings availableNaprod Life Sciences Private Limited reported revenue of ₹219.65 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹219.65 Cr ▲ 1%
Net profit · FY 2025
₹19.5 Cr margin 8.9%
EBITDA · FY 2025
₹34.7 Cr margin 15.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 4%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 3%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 1% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹219.65 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34.7 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.5 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | ||||
| Net Profit Margin | 8.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Naprod Life Sciences Private Limited, buy the company report.
Board of directors of Naprod Life Sciences Private Limited
Naprod Life Sciences has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Babulal Jain Also directs: Medorbis Trade LLP, Miracalus Pharma Private Limited, Samrudh Pharmaceuticals Private Limited and 2 more | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
| Mohan Babulal Jain Also directs: Medorbis Trade LLP, Miracalus Pharma Private Limited, Samrudh Pharmaceuticals Private Limited and 2 more | Director | 02 Mar 1994 | 32 Years 7 Months | Current |
| Aarya Mohan Jain Also directs: Medorbis Trade LLP, Miracalus Pharma Private Limited, Mac-Chem Products (India) Private Limited and 1 more | Director | 13 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Naprod Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India | |||
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India | |||
| Naprod Life Sciences Private Limitedthis company | ₹219.65 Cr (FY 2025) | ₹19.5 Cr | 8.9% | 1.0% | 504 | Mumbai, Maharashtra, India |
| Makson Healthcare Private Limited | ₹217.91 Cr (FY 2024) | -2.0% | Mandideep, Madhya Pradesh, India | |||
| Relax Pharmaceuticals Private Limited | ₹215.76 Cr (FY 2024) | 29.0% | Saharanpur, Uttar Pradesh, India | |||
| Rivpra Formulation Private Limited | ₹215.35 Cr (FY 2025) | -7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Naprod Life Sciences Private Limited, buy the company report.
Auditor
Naprod Life Sciences Private Limited is audited by SOHAN S. JAIN & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SOHAN S. JAIN & Co. | FY 2023 | 110327W |
Shareholding
The shareholding of Naprod Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Naprod Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹56.1 Cr
Satisfied charges
₹9.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2022 | 100589260 | Others | ₹56 Cr | Open | |
| 02 Jan 2020 | 100406036 | Others | ₹10 Lakh | Open | |
| 22 Feb 2007 | 10150078 | Icici Bank Limited | ₹4.75 Cr | Satisfied | |
| 09 Dec 1997 | 90240409 | State Bank of India | ₹1.91 Cr | Satisfied | |
| 31 Mar 1997 | 90238307 | Maharashtra State Financial Corporation | ₹1.21 Cr | Satisfied |
To see the full charge records of Naprod Life Sciences Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Naprod Life Sciences Private Limited has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.52 Cr; the latest was in March 2022.
Total deals
9
Secondary share transfers
8
Funding round
1
Disclosed funding
₹1.52 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Manish B Jain HUF, an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Naprod Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Naprod Life Sciences Private Limited has 16 court cases on record: 4 filed by Naprod Life Sciences, 12 filed against it. 1 case is pending and 15 are disposed.
Total cases
16
Filed by the company
4
Filed against the company
12
Pending
1
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 10 | 0 |
| District courts | 1 | 1 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against The Kerala Medical Services Corporation Ltd. and 2 others | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by Deputy Commissioner of Income Tax Circle 2 (3X1) | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Deputy Commissioner of Income Tax and 3 Ors. and 3 others | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by PR. Commissioner of Income Tax-10, Mumbai | Disposed |
To see the full case history of Naprod Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Naprod Life Sciences Private Limited was last rated by Crisil on 28 Aug 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 28 Aug 2019 |
To see the full credit ratings and regulatory alerts of Naprod Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Naprod Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Naprod Life Sciences Private Limited has a workforce of 504 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
504
Active EPFO establishments
1
Employee growth
1.2%
GST
Naprod Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN1291M1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Naprod Life Sciences Private Limited, buy the company report.
Recent activity
Naprod Life Sciences Private Limited has 16 board changes on record since 1994: 3 appointments and 13 cessations. The latest: Sangeeta Mohan Jain ceased to be Additional Director on 25 Mar 2025.
AGM
Naprod Life Sciences Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Naprod Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Sangeeta Mohan Jain ceased to be Additional Director.
Appointed
Aarya Mohan Jain was appointed as Director.
Charges
A charge with Others of Rs. 56.00 Cr registered on 27 Jun 2022 with Charge ID 100589260 was modified on 04 Mar 2024.
Charges
A charge with Others amounted to Rs. 56.00 Cr with Charge ID 100589260 was registered on 27 Jun 2022.
Ceased
Babulal Kesharimal Jain ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.10 Cr with Charge ID 100406036 was registered on 02 Jan 2020.
Ceased
Manish Babulal Jain ceased to be Additional Director.
Appointed
Manish Babulal Jain was appointed as Director.
Charges
A charge registered on 09 Dec 1997 via Charge ID 90240409 with State Bank Of India was fully satisfied on 02 Jan 2018.
Charges
A charge registered on 01 Nov 1994 via Charge ID 90239987 with State Bank Of India was fully satisfied on 02 Jan 2018.
21 earlier events are in the company report.
Frequently asked questions
Naprod Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 July 1990 (36+ years old) and is registered under CIN U24230MH1990PTC057496.
Naprod Life Sciences has 3 current directors:
- Manish Babulal Jain - Director
- Mohan Babulal Jain - Director
- Aarya Mohan Jain - Director
The latest financial statements of Naprod Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Naprod Life Sciences is 27AAACN1291M1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Naprod Life Sciences is U24230MH1990PTC057496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Naprod Life Sciences has 16 court cases on record: 4 filed by the company and 12 filed against it. 1 is pending. Most are in the high courts.
Naprod Life Sciences was incorporated on 30 July 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Naprod Life Sciences has 9 deals on record (8 secondary share transfers, 1 funding round), with disclosed funding of ₹1.52 Cr; the latest was in March 2022.
The peers of Naprod Life Sciences by revenue are Venus Biosciences Private Limited, Nestor Pharmaceuticals Limited, Concept Pharmaceuticals Limited, Makson Healthcare Private Limited, Relax Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sangeeta Mohan Jain ceased to be Additional Director on 25 Mar 2025. Aarya Mohan Jain was appointed as Director on 13 Mar 2025. Babulal Kesharimal Jain ceased to be Director on 08 Jan 2021. Naprod Life Sciences has 16 board changes on record in total.
Yes, Naprod Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0000619).